Literature DB >> 15546126

Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia.

Pascal de Lagausie1, Anthony de Buys-Roessingh, Latifa Ferkdadji, Julien Saada, Sophie Aisenfisz, Christine Martinez-Vinson, Xavier Fund, Jean Michel Cayuela, Michel Peuchmaur, Jean Christophe Mercier, Dominique Berrebi.   

Abstract

Congenital diaphragmatic hernia (CDH) is a major cause of refractory respiratory failure in the neonatal period and is characterized by persistent pulmonary hypertension of the newborn (PPHN) and pulmonary hypoplasia. Endothelin-1 (ET-1) dysregulation may play a significant role in the pathophysiology of PPHN and ET-1 acts through binding to type A (ETA) and type B (ETB) receptors. Therefore, ETA and ETB receptor protein expression was studied using immunohistochemistry in 10 lung specimens obtained from newborns with CDH, and 4 normal lung specimens, in order to explore whether dysregulation of ETA and ETB expression contributes to PPHN. ETA and ETB mRNAs were then quantified using real-time RT-PCR in laser-microdissected pulmonary resistive arteries. In the lungs of newborns with CDH, immunohistochemistry of both ETA and ETB receptors demonstrated over-expression in the thickened media of pulmonary arteries. Using laser microdissection and real-time RT-PCR, higher levels of ETA and ETB mRNA were found in CDH pulmonary arteries than in controls: this increase was more pronounced for ETA mRNA. This study provides the first demonstration of ET-1 receptor dysregulation in association with structural alteration of pulmonary arteries in newborns with CDH and PPHN. This dysregulation preferentially affects the ETA receptor. These results suggest that dysregulation of ET-1 receptors may contribute to PPHN associated with CDH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15546126     DOI: 10.1002/path.1677

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  20 in total

1.  Acute effect of a dual ETA-ETB receptor antagonist on pulmonary arterial vasculature in preterm lamb fetuses with surgically induced diaphragmatic hernia.

Authors:  Eleuthère Stathopoulos; Pierre-Henri Rolland; Géraldine Héry; Catherine de Magnée; Olivier Paut; Emmanuelle Couchot; Olivier Leprêtre; Jean-Michel Guys; Pascal de Lagausie
Journal:  Pediatr Surg Int       Date:  2010-08-10       Impact factor: 1.827

2.  Effects of combined hyperoxia and cyclooxygenase inhibition in neonatal rat lungs.

Authors:  Katherine M Kuniyoshi; Romy S Brock; Bisrat H Gebrekristos; Matthew Abad-Santos; Dinh Hoang; Houchang D Modanlou; Brigham C Willis; Kay D Beharry
Journal:  Am J Transl Res       Date:  2010-06-08       Impact factor: 4.060

3.  Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme.

Authors:  Wen-Tsong Hsieh; Wei-Lan Yeh; Ruo-Yuo Cheng; Chingju Lin; Cheng-Fang Tsai; Bor-Ren Huang; Caren Yu-Ju Wu; Hsiao-Yun Lin; Shiang-Suo Huang; Dah-Yuu Lu
Journal:  J Neurooncol       Date:  2014-04-23       Impact factor: 4.130

4.  Defective angiogenesis in hypoplastic human fetal lungs correlates with nitric oxide synthase deficiency that occurs despite enhanced angiopoietin-2 and VEGF.

Authors:  Olivier Boucherat; Marie-Laure Franco-Montoya; Christophe Delacourt; Jelena Martinovic; Virginie Masse; Caroline Elie; Bernard Thébaud; Alexandra Benachi; Jacques R Bourbon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-03-26       Impact factor: 5.464

5.  Looking beyond PPHN: the unmet challenge of chronic progressive pulmonary hypertension in the newborn.

Authors:  Candice D Fike; Judy L Aschner
Journal:  Pulm Circ       Date:  2013-11-19       Impact factor: 3.017

6.  Altered expression and signal transduction of endothelin-1 receptors in heritable and idiopathic pulmonary arterial hypertension.

Authors:  Jun Yu; Linda Taylor; Jamie Wilson; Suzy Comhair; Serpil Erzurum; Peter Polgar
Journal:  J Cell Physiol       Date:  2013-02       Impact factor: 6.384

7.  Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.

Authors:  Emily Z Xu; Crystal Kantores; Julijana Ivanovska; Doreen Engelberts; Brian P Kavanagh; Patrick J McNamara; Robert P Jankov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-01       Impact factor: 4.733

8.  Antenatal maternally-administered phosphodiesterase type 5 inhibitors normalize eNOS expression in the fetal lamb model of congenital diaphragmatic hernia.

Authors:  Eveline H Shue; Samuel C Schecter; Wenhui Gong; Mozziyar Etemadi; Michael Johengen; Corey Iqbal; S Christopher Derderian; Peter Oishi; Jeffrey R Fineman; Doug Miniati
Journal:  J Pediatr Surg       Date:  2013-10-05       Impact factor: 2.545

9.  Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension.

Authors:  Olga Rafikova; Ruslan Rafikov; Sanjiv Kumar; Shruti Sharma; Saurabh Aggarwal; Frank Schneider; Danny Jonigk; Stephen M Black; Stevan P Tofovic
Journal:  Free Radic Biol Med       Date:  2012-11-29       Impact factor: 7.376

10.  Upregulation of endothelin receptors A and B in the nitrofen induced hypoplastic lung occurs early in gestation.

Authors:  Jens Dingemann; Takashi Doi; Elke Ruttenstock; Prem Puri
Journal:  Pediatr Surg Int       Date:  2010-01       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.